Factsheets

Insurance Europe’s response to the EBA’s call for evidence on the PRIIPs Regulation review, highlighting concerns over the short consultation timeline, market impact of Insurance-based Investment Products (IBIPs), and challenges in aligning regulatory changes with consumer testing and digital adaptation.

EFAMA’s response to the EBA’s call for evidence on the PRIIPs Regulation review, advocating for stability in the PRIIP KID framework post-2022 implementation, emphasizing investor adaptation needs, and cautioning against frequent regulatory changes to avoid costs and maintain confidence.

European Issuers' response to the EBA's call for evidence on the PRIIPs Regulation, focusing on retail investor protection, Key Information Document (KID) effectiveness, digital adaptation, and corporate bond treatment under the EU's retail investment strategy.

EUSIPA's response to the EBA's call for evidence on the PRIIPs Regulation, highlighting concerns over frequent regulatory changes, alignment with MiFID rules, and the need for an evidence-based review of retail investment product disclosures and investor protection frameworks.

Finance Denmark’s response to the EBA’s call for evidence on the PRIIPs Regulation, assessing the effectiveness of Key Information Documents (KIDs) for retail investors, challenges in comparability, digital adaptation, and the transition from UCITS KIID to PRIIPs KID by December 2022.

Finance Finland’s response to the EBA’s call for evidence on the PRIIPs Regulation review, addressing retail investor protection, KID effectiveness, digital adaptation, and implementation challenges in Finland, while advocating coordinated regulatory changes.

EBA, EIOPA, and ESMA call for evidence on the PRIIPs Regulation review, seeking stakeholder input on the Key Information Document (KID), comprehension alerts, enforcement, digital adaptation, and scope to shape retail investor protection advice for the European Commission by April 2022.

France Invest’s response to the EBA’s call for evidence on the PRIIPs Regulation, assessing its application, effectiveness, and digital adaptation, with a focus on retail investor protection, venture capital, and private equity funds in France.

French Banking Federation response to the EBA’s call for evidence on PRIIPs Regulation, addressing retail investor protection, KID effectiveness, regulatory consistency with MiFID II, and concerns over frequent documentation changes for investment products.

German Association of Actuaries (DAV) responds to the European Commission's call for evidence on the PRIIPs Regulation, providing feedback on retail investor protection, KID effectiveness, digital adaptation, and regulatory scope ahead of the 2022 retail investment strategy review.

Swedish Securities Markets Association responds to EBA’s call for evidence on PRIIPs Regulation, addressing KID usage, comprehension alerts, digital adaptation, and enforcement effectiveness to support the EU’s retail investment strategy review by April 2022.

AFME's response to the European Commission and ESAs' call for evidence on the PRIIPs Regulation, focusing on retail investor protection, KID effectiveness, digital adaptation, and regulatory scope for structured products, bonds, and insurance-based investments.

The Investment Association’s response to the EBA’s call for evidence on the PRIIPs Regulation, addressing retail investor protection, KID effectiveness, digital adaptation, and alignment with MiFID II and IDD frameworks ahead of the 2022 review.

WWF European Policy Office submission to the EBA’s call for evidence on the PRIIPs Regulation, advocating for enhanced sustainability disclosures in Key Information Documents (KIDs) to improve retail investor decision-making on environmental impacts and product comparability.

International Capital Market Association (ICMA) responds to the European Commission and ESAs' call for evidence on the PRIIPs Regulation, focusing on retail investor protection, KID effectiveness, digital adaptation, and regulatory scope ahead of the 2022 retail investment strategy review.